Influenza: A Patient’s Perspective
A patient shares her life-threatening influenza illness.
Studies Show Influenza and Pneumonia Vaccines May Reduce Risk of Developing Alzheimer’s
Two studies show the influenza (flu) and pneumonia vaccines lessen the risk of developing Alzheimer’s disease (AD) in the future.
Competition Among Clinics Increased Influenza Vaccine Rates Among Patients, Study Showed
A recent experiment found offering healthcare providers financial incentives and creating competition by informing clinics how their performance ranked relative to others were effective in increasing influenza (flu) vaccine rates among patients.
Are We Finally Closing In On a Universal Influenza Vaccine?
For decades, scientists have discussed the concept of a “universal” flu vaccine that could provide broad protection against seasonal and pandemic influenza viruses, and we now have a number of promising vaccine candidates with a realistic chance to fulfill the dream.
Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals
A new study shows cardiovascular outcomes may improve in individuals with hypertension if they receive the influenza (flu) vaccine during the flu season.
Skin Patch Shows Promise for Delivery of Influenza Vaccine
Researchers at the University of Rochester Medical Center in New York City have developed a new type of skin patch that could replace needles as a method to deliver the influenza (flu) vaccine.
Researchers Uncover How Human Immunity Evades Influenza Virus
A new study that looked at how the influenza (flu) virus escapes antibodies found the site of the escape mutation varies among most individuals’ sera.
NIH to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine
The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of two licensed seasonal influenza vaccines administered with or without novel adjuvants.
Anti-Influenza Hyperimmune Immune Globulin Not Effective in Hospitalized Adults with Influenza Infection
A trial was conducted to assess the safety and efficacy of hIVIG (in conjunction with standard care) in adults hospitalized with laboratory-confirmed influenza A or B infection.
